APA (7th ed.) Citation

Chandran, N. S., Bhupendrabhai, M. N., Tan, T. T., Zhang, B., Lim, S. K., Choo, A. B. H., & Lai, R. C. (2025). A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers. Cytotherapy (Oxford, England), 27(5), 633-641. https://doi.org/10.1016/j.jcyt.2025.01.007

Chicago Style (17th ed.) Citation

Chandran, Nisha Suyien, Monil Nagad Bhupendrabhai, Thong Teck Tan, Bin Zhang, Sai Kiang Lim, Andre Boon Hwa Choo, and Ruenn Chai Lai. "A Phase 1, Open-label Study to Determine Safety and Tolerability of the Topical Application of Mesenchymal Stem/stromal Cell (MSC) Exosome Ointment to Treat Psoriasis in Healthy Volunteers." Cytotherapy (Oxford, England) 27, no. 5 (2025): 633-641. https://doi.org/10.1016/j.jcyt.2025.01.007.

MLA (9th ed.) Citation

Chandran, Nisha Suyien, et al. "A Phase 1, Open-label Study to Determine Safety and Tolerability of the Topical Application of Mesenchymal Stem/stromal Cell (MSC) Exosome Ointment to Treat Psoriasis in Healthy Volunteers." Cytotherapy (Oxford, England), vol. 27, no. 5, 2025, pp. 633-641, https://doi.org/10.1016/j.jcyt.2025.01.007.